SCHEMBL5880382

SCHEMBL5880382

O=C1CCC(=O)N1OC(O)=S

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PARL Q9H300 3/20 0.36
MGLL Q99685 2/20 0.33
ALOX12 P18054 1/20 0.32
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7524687 0.82 PARL (0.38) PARLMGLLALOX12
SCHEMBL4618888 0.78 GLA (0.32) PARLMGLL
Bicarbonate SCHEMBL28277653 0.75 MGLL (0.36) PARLMGLLALOX12KMT2A
Bicarbonate SCHEMBL28277654 0.75 MGLL (0.36) PARLMGLLALOX12KMT2A
SCHEMBL118685 0.75 PARL (0.41) PARLMGLLALOX12KMT2A
SCHEMBL865136 0.74 MGLL (0.40) PARLMGLLALOX12KMT2A
SCHEMBL17447 0.74 MGLL (0.37) PARLMGLLALOX12
SCHEMBL15321160 0.73 MGLL (0.36) PARLMGLLALOX12KMT2A
SCHEMBL2826280 0.73 MGLL (0.30) MGLL
SCHEMBL3276680 0.72 MGLL (0.36) PARLMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2006522140-A 2006-09-28 JP claimed
EP-1608380-A2 POLYMERIC DRUG AGENTS FOR THE TREATMENT OF FIBROTIC DISORDERS Vectramed, Inc. (US) 2005-12-28 EP claimed
WO-2004089311-A2 POLYMERIC DRUG AGENTS FOR THE TREATMENT OF FIBROTIC DISORDERS VECTRAMED, INC. (US) 2004-10-21 WO claimed
EP-1176985-A2 ENZYMATICALLY ACTIVATED POLYMERIC DRUG CONJUGATES Vectramed, Inc. (US) 2002-02-06 EP disclosed
WO-2000064486-A2 ENZYMATICALLY ACTIVATED POLYMERIC DRUG CONJUGATES VECTRAMED, INC. (US) 2000-11-02 WO disclosed